Healthcare doesn’t slow down. Here’s what’s worth your attention this week: a trend, an insight, a tactic, and an opinion. Designed to start your week sharp, in the time it takes to drink your first cup of coffee.
Trend: Content is becoming a sales qualification tool.
B2B healthcare companies are quietly repositioning their content: articles, webinars, lead magnets, as top-of-funnel qualification infrastructure rather than brand awareness plays. The data supports the shift: according to 6sense’s 2025 B2B Buyer Experience Report, buyers select a preferred vendor before ever engaging a seller, and that pre-contact favorite wins the deal roughly 80% of the time. When a prospect has already consumed multiple pieces of thought leadership before a discovery call, the sales conversation starts at a different level.
Marketing and sales teams that share content engagement data are shortening early-stage cycles and entering calls with a clearer picture of where a buyer is in their decision process. Among B2B clients who first engage with high-quality content, nearly one-third made their first inquiry through a thought leadership asset, and those buyers require 20% fewer interactions before signing a deal. In a sales cycle that runs more than a year and spans 22 touchpoints, that reduction compounds quickly. The content isn’t just building brand. It’s doing pre-qualification work that used to require two or three additional touchpoints.
Insight: The follow-up gap is costing B2B healthcare deals before they ever close.
According to SPOTIO’s 2026 Sales Statistics, 80% of sales require five or more follow-ups to close, yet 44% of reps give up after one attempt. In a sales cycle that runs more than a year and touches 22 people across an organization, that gap is not a minor inefficiency. It is a structural leak in the pipeline. The deals most likely to close are often the ones that go cold not because the buyer lost interest, but because the seller stopped showing up. In B2B healthcare, where relationships and trust drive decisions more than price or features, consistent follow-through is not just a tactic. It is the difference between a deal that closes and one that quietly moves to a competitor who stayed in the room.
Tool: Fathom, for B2B healthcare sellers who are still writing their own call notes.
Fathom is an AI meeting recorder and notetaker that automatically captures, transcribes, and summarizes sales calls, then syncs action items and next steps directly to your CRM. For B2B healthcare sellers managing long, complex sales cycles with multiple stakeholders, the operational value is straightforward: no more post-call admin, no detail lost between a 14-person buying committee call and the follow-up, and a searchable record of every conversation in the pipeline.
The healthcare-specific use case: use Fathom’s call summaries to track which stakeholders raised compliance or budget concerns, which conversations stalled, and which talking points moved deals forward. Over a pipeline that runs more than a year, that institutional memory is the difference between a rep who knows the account and one who’s starting over every call.
Free plan available. Paid plans start at $19/month per user.
Opinion: The vendors winning in B2B healthcare are not the ones with the biggest booths.
The vendors getting ahead are the ones who showed up consistently, said something useful, and made buyers feel understood long before anyone asked for a meeting. In a sales environment where buyers form their shortlist before they ever engage a seller, the real competition is not happening in the demo. It is happening in the months before it, in the content buyers are reading, the peers they are asking, and the names that keep coming up. The organizations investing in those earlier windows are building brand awareness and the trust that closes deals.
Full breakdowns and deeper dives at briviohealth.com.
